Good At

Precision hepatectomy technology treats various benign and malignant liver and gallbladder diseases (including hepatolithiasis, hepatic hemangioma, liver cysts, liver cancer, bile duct cancer, gallbladder cancer and hepatoblastoma, etc.), and is proficient in various liver transplantation operations (including classic orthotopic, piggyback, adult in vivo, child in vivo, split and orthotopic assisted liver transplantation, etc.), and has accumulated rich experience in the diagnosis, treatment and perioperative management of complex liver and gallbladder diseases.

Introduction

Hang Hualian, male, MD, postdoctoral fellow at Cleveland Medical Center and senior visiting scholar at New York School of Medicine, chief physician, professor and doctoral supervisor of the Liver Surgery and Liver Transplantation Center, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. He has been engaged in clinical, teaching, and scientific research in hepatobiliary surgery for nearly 20 years. He is good at precise hepatectomy technology for the treatment of various benign and malignant liver and gallbladder diseases (including liver cancer, bile duct cancer, gallbladder cancer, hepatolithiasis, hepatic hemangioma, liver cysts, etc.), and is proficient in various liver transplantation operations (including classic orthotopic, piggyback, adult living in vivo, children living in vivo, splitting and orthotin-assisted liver transplantation, etc.), and has accumulated rich experience in the diagnosis, treatment and perioperative management of complex liver and gallbladder diseases.